Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Aptamers as promising molecular recognition elements for diagnostics and therapeutics in the central nervous system

McConnell EM, Holahan MR, DeRosa MC.

Nucleic Acid Ther. 2014 Dec;24(6):388-404. doi: 10.1089/nat.2014.0492.

Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement

Espay AJ, LeWitt PA, Kaufmann H.

Mov Disord. 2014 Dec;29(14):1710-9. doi: 10.1002/mds.26048. Epub 2014 Oct 9.

Neuropathology of multiple system atrophy: new thoughts about pathogenesis

Jellinger KA.

Mov Disord. 2014 Dec;29(14):1720-41. doi: 10.1002/mds.26052. Epub 2014 Oct 9.

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study

Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K; PARS Investigators.

Neurology. 2014 Nov 4;83(19):1739-46. doi: 10.1212/WNL.0000000000000960. Epub 2014 Oct 8.

Eyelid tremor in a patient with anti-caspr2 antibody-related encephalitis

Ueno S, Hirano M, Sakamoto H, Kusunoki S, Nakamura Y.

Case Rep Neurol. 2014 Aug 27;6(2):222-5. doi: 10.1159/000366408. eCollection 2014 May.

Understanding the Burden on Caregivers of People with Parkinson's: A Scoping Review of the Literature

Bhimani R.

Rehabil Res Pract. 2014;2014:718527. doi: 10.1155/2014/718527. Epub 2014 Sep 14.

Aggravated Dysphagia caused by cervical osteophyte in a patient with Parkinson disease

Lee SH, Bae SO, Paik NJ.

Am J Phys Med Rehabil. 2014 Dec;93(12):e19. doi: 10.1097/PHM.0000000000000218.

[Diagnostics and therapy of "freezing of gait" in patients with Parkinson's disease]

Amarell M, Cepuran F, Timmermann L, Allert N, Barbe MT.

Fortschr Neurol Psychiatr. 2014 Oct;82(10):593-605. doi: 10.1055/s-0034-1385164. Epub 2014 Oct 9.

Neural cell adhesion molecules belonging to the family of leucine-rich repeat proteins

Winther M, Walmod PS.

Adv Neurobiol. 2014;8:315-95. doi: 10.1007/978-1-4614-8090-7_14.

Safinamide for the treatment of Parkinson's disease

Kandadai RM, Jabeen SA, Kanikannan MA, Borgohain R.

Expert Rev Clin Pharmacol. 2014 Nov;7(6):747-59. doi: 10.1586/17512433.2014.968555. Epub 2014 Oct 10.

Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease

Broadstock M, Ballard C, Corbett A.

Expert Rev Clin Pharmacol. 2014 Nov;7(6):779-86. doi: 10.1586/17512433.2014.966814. Epub 2014 Oct 10.

Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson's disease?

Ciurleo R, Di Lorenzo G, Bramanti P, Marino S.

Biomed Res Int. 2014;2014:519816. doi: 10.1155/2014/519816. Epub 2014 Sep 11.

New developments in the management of neurogenic orthostatic hypotension

Biaggioni I.

Curr Cardiol Rep. 2014 Nov;16(11):542. doi: 10.1007/s11886-014-0542-z.

Great expectations: the placebo effect in Parkinson's disease

Lidstone SC.

Handb Exp Pharmacol. 2014;225:139-47. doi: 10.1007/978-3-662-44519-8_8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias